Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.

Schorn, S; Vogel, T; Demir, IE; Demir, E; Safak, O; Friess, H; Ceyhan, GÜRALP

doi:10.1016/j.pan.2020.10.043

Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? - A systematic review with meta-analysis of randomized-controlled trials.

Schorn S., Vogel T., Demir I., Demir E., Safak O., Friess H., ...Daha Fazla

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], cilt.20, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 20
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.pan.2020.10.043
Dergi Adı: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Objective: Postoperative pancreatic fistula/POPF is the most feared complication in pancreatic surgery. Although several systematic reviews investigated the impact of somatostatin analogues on POPF, no stratification was performed regarding type of pancreatic resection (pancreaticoduodenectomy/PD; distal pancreatectomy/DP) and different somatostatin analogues.